Advertisement

AACR progress report highlights AI’s role in research and clinical care

Obstacles to progress include systemic disparities and dwindling appropriations

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
McKenzie Prillaman
McKenzie Prillaman
Reporter
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

The American Association for Cancer Research-Novocure Career Development Award for Cancer Research represents a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage early-career investigators to enter the TTFields research field. 
Advertisement
Advertisement